November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
May 10, 2026 - 10:18
AI Isn't Stealing Your Job. Here's the Real StoryNew York -- The fear that artificial intelligence will wipe out millions of jobs has dominated headlines for years. But the reality is far less dramatic and more complicated than the doomsayers...
May 9, 2026 - 21:48
Marqeta Appoints Lukasz Strozek As Chief Technology OfficerMarqeta, the Oakland-based card issuing platform, has appointed Lukasz Strozek as its next Chief Technology Officer. The appointment takes effect on May 18, 2026. In his new role, Strozek will...
May 9, 2026 - 01:08
What is ‘Premium Content’ on Power Technology?Power Technology has launched a new offering called Premium Content, a free subscription service designed to give readers access to deeper industry analysis and exclusive reports. The service moves...
May 8, 2026 - 00:11
Yale-led technology receives first-ever FDA approval for breast cancer treatmentA new breast cancer treatment rooted in Yale University research has received its first-ever approval from the U.S. Food and Drug Administration. The therapy, developed by the biotech company...